Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$60.3 - $70.67 $681,390 - $798,571
11,300 Added 251.11%
15,800 $1.09 Million
Q2 2024

Aug 14, 2024

SELL
$63.57 - $92.93 $25,428 - $37,172
-400 Reduced 8.16%
4,500 $287,000
Q1 2024

May 15, 2024

SELL
$69.21 - $94.27 $200,708 - $273,383
-2,900 Reduced 37.18%
4,900 $460,000
Q4 2023

Feb 14, 2024

BUY
$54.91 - $74.64 $43,928 - $59,712
800 Added 11.43%
7,800 $573,000
Q3 2023

Nov 14, 2023

SELL
$61.34 - $75.77 $466,184 - $575,852
-7,600 Reduced 52.05%
7,000 $436,000
Q2 2023

Aug 14, 2023

SELL
$69.1 - $84.02 $6,909 - $8,402
-100 Reduced 0.68%
14,600 $1.08 Million
Q1 2023

May 15, 2023

BUY
$65.49 - $78.84 $491,174 - $591,300
7,500 Added 104.17%
14,700 $1.16 Million
Q4 2022

Feb 14, 2023

SELL
$54.36 - $69.91 $282,672 - $363,532
-5,200 Reduced 41.94%
7,200 $492,000
Q3 2022

Nov 14, 2022

SELL
$48.91 - $69.04 $1.02 Million - $1.44 Million
-20,900 Reduced 62.76%
12,400 $658,000

Others Institutions Holding BRKR

About BRUKER CORP


  • Ticker BRKR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 148,138,000
  • Market Cap $7.91B
  • Description
  • Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, ...
More about BRKR
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.